JPWO2024177126A5 - - Google Patents
Info
- Publication number
- JPWO2024177126A5 JPWO2024177126A5 JP2025502778A JP2025502778A JPWO2024177126A5 JP WO2024177126 A5 JPWO2024177126 A5 JP WO2024177126A5 JP 2025502778 A JP2025502778 A JP 2025502778A JP 2025502778 A JP2025502778 A JP 2025502778A JP WO2024177126 A5 JPWO2024177126 A5 JP WO2024177126A5
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- disease
- alkyl
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025134721A JP2025169332A (ja) | 2023-02-24 | 2025-08-13 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023027437 | 2023-02-24 | ||
| JP2023027437 | 2023-02-24 | ||
| PCT/JP2024/006429 WO2024177126A1 (ja) | 2023-02-24 | 2024-02-22 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025134721A Division JP2025169332A (ja) | 2023-02-24 | 2025-08-13 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024177126A1 JPWO2024177126A1 (https=) | 2024-08-29 |
| JPWO2024177126A5 true JPWO2024177126A5 (https=) | 2025-07-18 |
| JP7729000B2 JP7729000B2 (ja) | 2025-08-25 |
Family
ID=92501358
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025502778A Active JP7729000B2 (ja) | 2023-02-24 | 2024-02-22 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
| JP2025134721A Pending JP2025169332A (ja) | 2023-02-24 | 2025-08-13 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025134721A Pending JP2025169332A (ja) | 2023-02-24 | 2025-08-13 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4671246A1 (https=) |
| JP (2) | JP7729000B2 (https=) |
| CN (1) | CN120731207A (https=) |
| WO (1) | WO2024177126A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025140708A1 (zh) * | 2023-12-31 | 2025-07-03 | 杭州百新生物医药科技有限公司 | 吡唑并嘧啶类化合物及其医药用途 |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20191679T1 (hr) * | 2013-10-30 | 2019-12-13 | Shanghai hengrui pharmaceutical co ltd | Derivati pirazolopirimidona ili pirolotriazona, postupak pripreme jednakih i njihove farmaceutske uporabe |
| WO2017205766A1 (en) * | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
| WO2020150114A1 (en) * | 2019-01-14 | 2020-07-23 | Innate Tumor Immunity, Inc. | Heterocyclic nlrp3 modulators, for use in the treatment of cancer |
| US12391675B2 (en) * | 2019-01-14 | 2025-08-19 | Innate Tumor Immunity, Inc. | NLRP3 modulators |
| CN114829345A (zh) * | 2019-12-27 | 2022-07-29 | 日本烟草产业株式会社 | 酰基磺酰胺化合物及其医药用途 |
| US20240382488A1 (en) * | 2021-03-29 | 2024-11-21 | Halia Therapeutics, Inc. | Nek7 inhibitors |
| WO2022216680A1 (en) * | 2021-04-05 | 2022-10-13 | Halia Therapeutics, Inc. | Nek7 inhibitors |
| CA3229401A1 (en) * | 2021-08-31 | 2023-03-09 | Japan Tobacco Inc. | 6-aminopyrazolopyrimidine compounds and medical use thereof |
| US20250114361A1 (en) * | 2022-08-29 | 2025-04-10 | Japan Tobacco Inc. | Pyrazolopyrimidine compound and pharmaceutical use thereof |
-
2024
- 2024-02-22 JP JP2025502778A patent/JP7729000B2/ja active Active
- 2024-02-22 EP EP24760424.2A patent/EP4671246A1/en active Pending
- 2024-02-22 WO PCT/JP2024/006429 patent/WO2024177126A1/ja not_active Ceased
- 2024-02-22 CN CN202480013810.2A patent/CN120731207A/zh active Pending
-
2025
- 2025-08-13 JP JP2025134721A patent/JP2025169332A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023036007A5 (https=) | ||
| JPWO2024177126A5 (https=) | ||
| JP2024514703A (ja) | ピペラジン構造を有するｐａｒｐ阻害剤、その調製方法およびその医薬的使用 | |
| JP2024120882A5 (https=) | ||
| JP2024032686A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2003531103A5 (https=) | ||
| RU2013156361A (ru) | Новые соединения | |
| JP2016535784A5 (https=) | ||
| ATE255093T1 (de) | Benzamidverbindung und ihre medizinische verwendung | |
| EP4482823A1 (en) | Di-cyclopropyl based il-17a modulators and uses thereof | |
| WO2018119087A1 (en) | Amino acid compounds and methods of use | |
| JP6380777B2 (ja) | ＰＩ３Ｋ、ｍＴＯＲ阻害薬としての縮合キノリン化合物 | |
| JP2012522759A5 (https=) | ||
| US5426106A (en) | Pyrrolo-pyridazinone derivatives | |
| EP0614363A1 (en) | Quinolone derivatives | |
| TW202208336A (zh) | Ｅｎｐｐ１調節劑及其用途 | |
| JP2022509206A5 (https=) | ||
| JP2019529460A5 (https=) | ||
| JP2007531742A5 (https=) | ||
| JP2022510587A5 (https=) | ||
| JP2020504176A (ja) | キナーゼを選択的に阻害する化合物及びその使用 | |
| JP2024514055A (ja) | β－ラクタマーゼ阻害剤としてのホウ酸誘導体 | |
| TW201118102A (en) | Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same | |
| JP2012509313A5 (https=) |